Application of Biofloc Technology for the culture of Heteropneustes fossilis (Bloch) in Bangladesh: stocking density,floc volume,growth performance,and profitability

Though Biofloc Technology is a new concept in Bangladesh, it provides advantages for improving aquaculture production in many countries, leading to achieve sustainable development goals. The objectives of this study were to determine the effects of stocking densities on the growth performance of stinging catfish (Heteropneustes fossilis) under Biofloc Technology and assess the economic prospects and business feasibilities. Fingerlings were stocked in unique 5000-L tanks with three stocking densities, i.e., 3500 fish/tank (Treatment-I), 4000 fish/tank (Treatment-II), 4500 fish/tank (Treatment-III). The treatments showed significant differences (P?<?0.05) considering the species-specific growth rate, feed conversion ratio, and protein efficiency ratio. Treatment-I had significantly ((P?<?0.05) higher final biomass (29.51 ± 0.04 kg/m³) than the other treatments. The present findings revealed that using a lower stocking density, the Biofloc Technology reduced ammonia (NH₃), nitrite (NO₂), nitrate (NO₃), TDS, and floc volume but significantly increased the dissolved oxygen. As a result, Treatment-I had generated significantly higher net income (BANGLADESHI TAKA—BDT 86,278.90) over the other treatments. Moreover, the NPV, net BCR, and RoR with 4% and 9% opportunity cost were also significantly higher in Treatment-I than other treatments. The internal rate of return (IRR) and SWOT analysis index indicates that investing in Biofloc Technology is far superior, and a stocking density of 3500 fish/tank (Treatment-I) resulted in a faster investment return.

     

Attenuation of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced gap junctional intercellular communication (GJIC) inhibition in MCF-10A cells by c9,t11-conjugated linoleic acid

The protective effect of c9,t11-conjugated linoleic acid (CLA) on the inhibition of gap junctional intercellular communication (GJIC) was examined in a human mammary epithelial cell line (MCF-10A) treated with 12-O-tetradecanoylphorbol-13-acetate (TPA), relative to t10,c12-CLA isomer. TPA inhibited GJIC in a dose-dependent and reversible manner and was associated with connexin 43 phosphorylation. Pretreatment of 20 μM c9,t11-CLA for 24 h prior to 60 nM TPA for 1 h prevented the inhibition of GJIC by reducing the phosphorylation of connexin 43 via suppressing extracellular signal-regulated kinases (ERK1/2) activation. Reactive oxygen species (ROS) accumulation by TPA was attenuated by c9,t11-CLA. The efficacy of c9,t11-CLA in protecting inhibition of GJIC, connexin 43 phosphorylation, and ROS production was superior to that of t10,c12-CLA. These results suggest that c9,t11-CLA, including t10,c12-CLA, prevents the carcinogenesis of MCF-10A cells by protecting down-regulation of GJIC during the cancer promotion stage, and lack of their toxicities could be an excellent indicator for the chemoprevention of breast cancer.     

Preventive effect of t,t-conjugated linoleic acid on 12-O-tetradecanoylphorbol-13-acetate-induced inhibition of gap junctional intercellular communication in human mammary epithelial MCF-10A cells

The anti-tumor promotional effects of t9,t11-conjugated linoleic acid (t9,t11-CLA) and t10,t12-CLA were evaluated on the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inhibition of gap junctional intercellular communication (GJIC) in the human mammary epithelial cell line MCF-10A. The results were compared to those obtained from c9,t11-CLA, which is a more effective anti-tumor promoter on TPA-induced GJIC inhibition in MCF-10A cells than t10,c12-CLA. Cells were treated with 20 μM t9,t11-CLA, t10,t12-CLA, or c9,t11-CLA for 24 h followed by 60 nM TPA for 1 h. Both t9,t11-CLA and t10,t12-CLA equally protected MCF-10A cells from TPA-induced inhibition of GJIC with inferior efficacy to c9,t11-CLA.The protection was due to the ameliorated phosphorylation of connexin43 via suppression of extracellular signal-regulated kinases (ERK1/2) activation. Suppression of TPA-induced reactive oxygen species (ROS) generation by t9,t11-CLA and t10,t12-CLA was less effective, relative to c9,t11-CLA. The results suggest that the anti-promotional activities of t9,t11-CLA and t10,t12-CLA are equal but less potent than c9,t11-CLA in TPA-treated MCF-10A cells. The activity might be mediated by the attenuation of ROS production in MCF-10A cells by preventing the downregulation of GJIC during the cancer promotion stage.